Patents Assigned to NEWVECTYS
  • Transient expression vectors, preparation and uses thereof
    Patent number: 10308955
    Abstract: The present invention describes a recombinant retroviral vector which cannot by itself achieve complete reverse transcription as well as its uses, in particular for transiently transferring in vitro, ex vivo or in vivo at least one ribonucleic acid sequence of interest in a cell. Such a transient transgene expression is of interest in the context of research, therapy and more generally in the field of biotechnology.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: June 4, 2019
    Assignee: NEWVECTYS
    Inventors: Chamsy Sarkis, Dorothee Altemir, Nicolas Grandchamp, Stephanie Philippe